DOCSLIB.ORG

EMBC Annual Report 2005

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
EMBC Annual Report 2005 EMBO | EMBC annual report 2005 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Frank Gannon, EMBO 4 preface by Susan Gasser, EMBO Council 6 preface by Marja Makarow, EMBC 8 past & present timeline 12 brief history 13 EMBO | EMBC | EMBL 14 EMBO actions 2005 17 EMBC actions 2005 19 EMBO & EMBC programmes and activities fellowship programme 23 courses & workshops programme 24 world activities 25 young investigator programme 26 women in the life sciences 27 science & society programme 28 electronic information programme 29 EMBO activities The EMBO Journal 32 EMBO reports 33 Molecular Systems Biology 34 journal subject categories 35 national science reviews 36 gold medal 37 award for communication in the life sciences 38 sectoral meetings 39 plenary lectures 40 communications offi ce 41 European Life Sciences Forum (ELSF) 42 ➔ 2 table of contents appendix EMBC delegates and advisers 46 EMBC scale of contributions 53 EMBO council members 2005 54 EMBO committee members & auditors 2005 55 EMBO council members 2006 56 EMBO committee members & auditors 2006 57 EMBO members elected in 2005 58 advisory editorial boards & senior editors 2005 66 long-term fellowship awards 2005 70 long-term fellowships: statistics 84 long-term fellowships 2005: geographical distribution 86 short-term fellowship awards 2005 88 short-term fellowships: statistics 102 short-term fellowships 2005: geographical distribution 104 young investigators 2005 106 young investigators 2000 – 2004 107 young investigators: statistics 108 young investigator lectures 2005 110 courses | workshops | conferences | symposia 2005 112 plenary lectures 2005 118 participation of women in EMBO activities: statistics 120 EMBO staff 124 events in 2006 courses | workshops | conferences | conference series | symposia 2006 128 plenary lectures 2006 134 other EMBO events 2006 136 organisations and acronyms 138 ➔ 3 preface EMBO & EMBC 2005 An awkward time warp surrounds annual 1200 applications for long-term fellowships and reports. The purpose of this type of publication interviewed 600 candidates as part of the selec- is to look back at the activities of the past year. tion process. This kind of input from the EMBO This can be a strange exercise for an organisa- community is a striking demonstration of the ef- tion like EMBO, where the emphasis is on dyna- fectiveness of EMBO as an organisation run by mism and moving forward with initiatives that scientists for scientists and helps us to deliver have a lasting impact on European research. activities that fulfi l the needs of the broader sci- One key benefi t of this retrospective exercise, entifi c community as they arise. Frank Gannon however, is the opportunity to review the over- EMBO journals also continued to play a ma- EMBO Executive Director all impact of events in 2005 and set benchmarks jor role and 2005 saw the launch of Molecular EMBC Secretary General for future activities. Systems Biology as a collaborative venture Taking a single snap-shot of 2005, the over- between EMBO and Nature Publishing Group whelming image is one of increasing demand for (NPG). The fi rst journal to be dedicated solely EMBO activities. EMBO programmes were more to the emerging fi eld of systems biology at the popular in 2005 than ever before. Long-term molecular level, Molecular Systems Biology and short-term fellowship applications were up also represents the fi rst publication by EMBO and requests for funding of EMBO Courses and of a journal along the open-access model. This Workshops increased dramatically. This points electronic journal will work together with the to a growing need and appreciation within the systems biology community to help structure scientifi c community for these activities. this emerging fi eld and to establish guidelines, Participation in EMBO Courses, Workshops standards and metrics for global complex da- and Conferences also reached an all-time high tasets. with more than 5,000 researchers benefi ting In addition to this direct input into research from this high standard of training. Add to this and scientifi c development, EMBO continued to participation in the EMBO Young Investigator extend its infl uence on national and European Programme, other networking activities and Sci- science policy in 2005. In its role as an advisory ence & Society meetings, and the direct impact body to the EMBC Member States, EMBO carried of EMBO on scientists – particularly in Europe – out a major review of the life sciences strategy becomes even more apparent. of the Spanish National Research Council (CSIC), All of this is possible because of the engage- as well as a more detailed assessment of one of ment of the scientifi c community. For example, the largest units of CSIC, the Spanish National in 2005 EMBO Members evaluated more than Biotechnology Centre (CNB). These reviews are ➔ 4 www.embo.org | [email protected] examples of EMBO’s contribution to raising the 2006 and is designed to strategically strengthen standards in science across Europe. research in the EMBC Member States. EMBC A more widely distributed effort, but one in also added to its membership in 2005 with the which EMBO was a lead player, resulted in the formal ratifi cation of the EMBC Agreement by establishment of the European Research Coun- Estonia and acceptance of the Slovak Republic cil (ERC). The Scientifi c Council of the ERC was as a new partner in this truly European consor- selected in 2005, with fi ve EMBO Members and tium. one EMBO Young Investigator contributing to This look in the rear-view mirror shows that the calibre of its membership. Again in the EU EMBO and EMBC have covered many miles in arena, EMBO and ELSF organised a petition for 2005 and that the resulting benefi ts are being greater funding for the framework programme, felt in laboratories all over Europe. The chal- attracting almost 20,000 signatures. 2005 also lenge to maintain this progressive contribution saw EMBO analyse current policy surround- to European research remains and will con- ing the use of animals in research. The results tinue to occupy the EMBO Members, Council, were communicated to the EMBC Delegates management, committees and EMBC such that in a special hearing, maximising the benefi t the 2006 report has even more good news to of this unique linkage between scientists, as convey. represented by EMBO, and policy-makers, as represented by EMBC. A further initiative by EMBC in 2005 was the establishment of a programme of EMBO Installation Grants. This scheme will launch in www.embo.org | [email protected] ➔ 5 preface EMBO & EMBC 2005 For over 40 years EMBO has promoted Euro- ours in publishing, in programmes that support pean molecular biology. During the last fi ve and encourage younger scientists and in tools of these I have had the privilege to serve as that help scientists in countries that are devel- either Vice-Chair or Chair of the EMBO Council. I oping a modern research infrastructure. leave that duty, no doubt like all Council Chairs After the departure of Iain Mattaj as Execu- before me, convinced that EMBO plays an ab- tive Editor of The EMBO Journal, this important solutely crucial role in the European scientifi c position was fi lled by another EMBL research arena. EMBO is unique in that it was created by scientist, Pernille Rørth. In 2005, Pernille inte- Susan Gasser scientists to serve scientists’ needs. But more grated smoothly into the team and the jour- EMBO Council Chair than that, it is involved in shaping the social nal is doing well under her guidance. Pernille fabric of our continent, as science becomes is supported by a panel of Senior Editors that increasingly relevant to the life of every Euro- includes Tim Hunt, Tony Hunter, Ari Helenius pean citizen. Furthermore, EMBO provides an and David Baulcombe. Given the breadth of The important demonstration of how bottom-up EMBO Journal, this additional input from top sci- administration can be rapidly responsive to the entists from different fi elds is highly benefi cial. ever-changing landscape of social and scientifi c The Senior Editors – who served their fi rst full attitudes and needs. year in 2005 – are helping on judgement calls as EMBO is concerned fi rst and foremost with well as bringing unconventional and insightful its core activities, which are pursued by a dedi- papers into the journal. cated staff that maintains rigorous standards Efforts to expand the links between The while keeping an eye on innovation. In addition, EMBO Journal and EMBO reports were contin- EMBO is constantly forging novel tools to pro- ued in 2005, with the aim of increasing the im- mote science at local, national and international pact of science published in both journals. Each levels – thereby evolving to match new chal- journal’s website now features highlights from lenges. Nothing exemplifi es this better than EM- the other. A further push in this direction has BO’s role in leading the way towards a European resulted in cross-publication of the tables of Research Council, which will unify and extend contents in the print versions of the journals. funding possibilities by providing a new tool for The biggest news on the publishing front competitive awards through EU support. in 2005, however, was the launch of Molecular What has EMBO achieved over the past year? Systems Biology – an open access, electronic Here I recap a few highlights among the EMBO journal developed together with Nature Publish- core activities that have led to novel endeav- ing Group (NPG). Molecular Systems Biology is ➔ 6 www.embo.org | [email protected] led by a panel of Senior Editors with outstand- The Young Investigator Programme is be- ing credentials and a small editorial team at coming increasingly well-known and its net- EMBO.
Load more

Recommended publications
  • Reinhart Heinrich (1946–2006) Pioneer in Systems Biology
    NEWS & VIEWS NATURE|Vol 444|7 December 2006 OBITUARY Reinhart Heinrich (1946–2006) Pioneer in systems biology. In biology, mathematical systems analysis where he showed that the flux of was until recently nearly invisible in the reaction was shared by several the dazzling light of twentieth-century enzymes. Much later, he extended discoveries. But it has emerged from the his ideas to signal-transduction shadows in the field of systems biology, pathways, introducing control a subject buoyed by immense data sets, coefficients to dynamic processes. conveyed by heavy computing power, and Sticking to real examples, such as addressing seemingly incomprehensible the Wnt signalling and MAP kinase forms of complexity. If systems biology has pathways, he again demonstrated heroes, one of them is Reinhart Heinrich, a that new properties and constraints former professor at the Humboldt University emerge when the individual steps in Berlin, who died on 23 October, aged are combined into a complete 60. His most famous accomplishment was pathway. metabolic control theory, published in Heinrich also pointed the way to 1974 with Tom Rapoport and formulated considerations of optimality theory independently by Henrik Kacser and James and evolution that will confront A. Burns in Edinburgh, UK. systems biology for the next From the 1930s to the 1960s, biochemists century. The question of evolution were busy describing metabolic pathways, lies just beneath any effort to just as molecular biologists today are understand biology. Yet in most feverishly trying to inventory the cell’s cases, physiological function and gene-transcription and signalling circuits. evolutionary change are considered The basic kinetic features of the enzymes in distinct and are investigated by the major pathways were studied in great different people.
    [Show full text]
  • May 29, 1990, NIH Record, Vol. XLII, No. 11
    May 29, 1990 Vol. XLII No. l l "The Second U.S. Department of Health Best Thing and Human Services About Payday" National Institutes o f Health e Recori Free Time and Services Given Nill Docs Answer Call to Help The Needy of Washington By Anne Barber A cry for help was mailed recently to hundreds of local physicians residing in the Washingt0n area asking for aid in caring for the needy by volunteering rime and services co che Zacchaeus Medical Clinic. That letter was signed by Dr. Allen L. Dollar, a volunteer physician at the clinic and a senior staff fellow working in NHLBI's Pathology Brand1. Dollar has worked at the clinic, on and off, for the past 13 ye11rs. He began volunteering while an undergraduate student at Georgetown University and worked there for 4 years as a physician's assistant before going off tO medi­ cal school in Baltimore. Returning to the Washington area 4 years ago, he rejoined the clinic. Zacchaeus is a private, nonprofit clinic operated entirely on private donations. le provides free physician visits, free laborat0ry A 111()unted member of the U.S. Park Police makes his way thrOtifl.h a a-owd of about I, 000 protesters out­ work and free medication co the poor. side Bid_~. 31 during a demomtration May 21 by fl,ay rights activists. Police arrested 82 people both 011 "When I joined the clinic in 1977, che ca111p11s and al an NTH rental buildinfl, in Rockville. majority of the patients were prostitutes from rhe 14th St. corridor and homeless people 'S wrm the NIH' from the nearby shelters," says Dollar.
    [Show full text]
  • Implications for Optimal Distributions of Enzyme Concentrations and for the Distribution of flux Control
    BioSystems 54 (1999) 1–14 www.elsevier.com/locate/biosystems Competition for enzymes in metabolic pathways: Implications for optimal distributions of enzyme concentrations and for the distribution of flux control Edda Klipp *, Reinhart Heinrich Humboldt Uni6ersity Berlin, Institute of Biology, Theoretical Biophysics, In6alidenstr. 42, D-10115, Berlin, Germany Received 1 February 1999; accepted 25 April 1999 Abstract The structures of biochemical pathways are assumed to be determined by evolutionary optimization processes. In the framework of mathematical models, these structures should be explained by the formulation of optimization principles. In the present work, the principle of minimal total enzyme concentration at fixed steady state fluxes is applied to metabolic networks. According to this principle there exists a competition of the reactions for the available amount of enzymes such that all biological functions are maintained. In states which fulfil these optimization criteria the enzyme concentrations are distributed in a non-uniform manner among the reactions. This result has conse- quences for the distribution of flux control. It is shown that the flux control matrix c, the elasticity matrix o, and the vector e of enzyme concentrations fulfil in optimal states the relations cTe=e and o Te=0. Starting from a well-balanced distribution of enzymes the minimization of total enzyme concentration leads to a lowering of the SD of the flux control coefficients. © 1999 Elsevier Science Ireland Ltd. All rights reserved. Keywords: Metabolic control theory; Evolutionary optimization; Competition; Enzyme concentrations; Flux control coefficient; Metabolic pathway; Mathematical modeling 1. Introduction optimal manner. On this basis one can draw conclusions about the actual states of metabolic The structural properties of metabolic systems systems using optimization criteria.
    [Show full text]
  • EMBC Annual Report 2007
    EMBO | EMBC annual report 2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Hermann Bujard, EMBO 4 preface by Tim Hunt and Christiane Nüsslein-Volhard, EMBO Council 6 preface by Marja Makarow and Isabella Beretta, EMBC 7 past & present timeline 10 brief history 11 EMBO | EMBC | EMBL aims 12 EMBO actions 2007 15 EMBC actions 2007 17 EMBO & EMBC programmes and activities fellowship programme 20 courses & workshops programme 21 young investigator programme 22 installation grants 23 science & society programme 24 electronic information programme 25 EMBO activities The EMBO Journal 28 EMBO reports 29 Molecular Systems Biology 30 journal subject categories 31 national science reviews 32 women in science 33 gold medal 34 award for communication in the life sciences 35 plenary lectures 36 communications 37 European Life Sciences Forum (ELSF) 38 ➔ 2 table of contents appendix EMBC delegates and advisers 42 EMBC scale of contributions 49 EMBO council members 2007 50 EMBO committee members & auditors 2007 51 EMBO council members 2008 52 EMBO committee members & auditors 2008 53 EMBO members elected in 2007 54 advisory editorial boards & senior editors 2007 64 long-term fellowship awards 2007 66 long-term fellowships: statistics 82 long-term fellowships 2007: geographical distribution 84 short-term fellowship awards 2007 86 short-term fellowships: statistics 104 short-term fellowships 2007: geographical distribution 106 young investigators 2007 108 installation
    [Show full text]
  • EMBO Facts & Figures
    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
    [Show full text]
  • Annual Report and Accounts 2007-08
    07/08 Annual report and accounts Medical Research Council Annual Report and Accounts 2007/08 Presented to Parliament by the Secretary of State for Innovation, Universities and Skills, and by the Comptroller and Auditor General in pursuance of Schedule I, Sections 2(2) and 3(3) of the Science and Technology Act 1965. Sir John Chisholm Chairman Sir Leszek Borysiewicz Deputy Chairman and Chief Executive Ordered by the House of Commons and printed on London: The Stationery Office 21 July 2008 Price: £18.55 HC 904 © Crown Copyright 2008 The text in this document (excluding the Royal Arms and other departmental or agency logos) may be reproduced free of charge in any format or medium providing it is reproduced accurately and not used in a misleading context. The material must be acknowledged as Crown copyright and the title of the document specified. Where we have identified any third party copyright material you will need to obtain permission from the copyright holders concerned. For any other use of this material please write to Office of Public Sector Information, Information Policy Team, Kew, Richmond, Surrey TW9 4DU or e-mail: [email protected] ISBN:978 0102956993 ANNUAL REPORT 2007/08 CONTENTS The Medical Research Council 4 Executive Summary 6 Foreword 10 Strategic coordination: MRC and NIHR in partnership 14 Delivering knowledge 16 Translating discovery 24 Developing people 32 Working in partnership 38 Public engagement 44 Promoting best practice in research 50 Supporting research excellence 54 Increasing business effectiveness 60 Management Commentary 2007/08 64 Remuneration Report 2007/08 70 Annual Accounts 2007/08 76 THE MEDICAL RESEarcH COUNCIL The Medical Research Council (MRC) is a publicly-funded organisation dedicated to improving human health.
    [Show full text]
  • Cv from Public Relations
    PROF. RUTH ARNON Formerly Vice-President of the Weizmann Institute of Science (1988-1997), is a world renowned Immunologist. Prof. Arnon joined the Weizmann Institute in 1960. Prior to her appointment as Vice-President, she served as Head of the Department of Chemical Immunology, and as Dean of the Faculty of Biology. From 1985 to 1994, she was the Director of the Institute's MacArthur Center for Molecular Biology of Tropical Diseases. Prof. Arnon has made significant contributions to the fields of vaccine development, cancer research and to the study of parasitic diseases. Along with Prof. Michael Sela, she developed Copaxone® a drug for the treatment of multiple sclerosis which was approved by the U.S. Food and Drug Administration, and is presently marketed in the USA, Canada the EU, Australia and many other countries worldwide. Prof. Arnon is a member of the Israel Academy of Sciences, and was the Chairperson of its Sciences division from 1995-2001 and was later elected as The Academy's Vice President. On the world scene, she is an elected member of the European Molecular Biology Organization (EMBO). She has served as President of the European Federation of Immunological Societies (EFIS), and as Secretary-General of the International Union of Immunological Societies (IUIS), and is presently a member of the European Union Research Advisory Board (EURAB) and served as the Senior Vice-President of the Association of Academies of Sciences in Asia (AASA). In 2004 Prof. Arnon served as the President of the Association of Academies of Sciences in Asia (AASA). Her awards include the Robert Koch Prize in Medical Sciences, Spain's Jiminez Diaz Memorial Prize, France's Legion of Honor, the Hadassah World Organization's Women of Distinction Award, the Wolf Prize for Medicine, the Rothschild Prize for Biology and the Israel Prize; Tel-Hai; Honorary doctorate from the University of the Negev, Ben- Gurion.
    [Show full text]
  • Metastasis and Invasion 3 – Metastasis Science Cancer
    CANCER SCIENCE 3 Cancer Science 3 – Metastasis and Invasion 3 – Metastasis Science Cancer www.ipsen.com 2FI 0069 Metastasis and Invasion Tuscany, May 20-23, 2007 24, rue Erlanger – 75016 Paris – Tel.: 33(0)1 44 96 10 10 – Fax: 33(0)1 44 96 11 99 COLLOQUES MÉDECINE ET RECHERCHE Fondation Ipsen SCIENTIFIC REPORT BY APOORVA MANDAVILLI 2 Fondation Ipsen is placed under the auspices of Fondation de France MOLECULAR MARKERS 3 4 Foreword by Inder M. Verma 7 Part I: Molecular markers 9 J. Michael Bishop Senescence and metastasis in mouse models of breast cancer 15 Joan Massagué Metastasis genes and functions 21 Zena Werb Transcriptional regulation of the metastatic program 25 Inder M. Verma BRCA1 maintains constitutive heterochromatin formation: a unifying hypothesis of its function 29 Tak Wah Mak The role of RhoC in development and metastasis 35 Part II: Motility and invasiveness 37 Robert Weinberg Mechanisms of malignant progression 43 Daniel Louvard Fascin, a novel target of b-catenin-Tcf signaling, is expressed at the invasive front of human colon cancer 49 Gerhard Christofori Distinct mechanisms of tumor cell invasion and metastasis 55 Douglas Hanahan Multiple parameters influence acquisition by solid tumors CONTENTS of a capability for invasive growth 59 Part III : Mechanisms of metastasis 61 Richard Hynes Cellular mechanisms contributing to metastasis 67 Ann Chambers Novel imaging approaches for studying tumor metastasis 73 Jeffrey Pollard Macrophages are a cellular toolbox that tumors sequester to promote their progression to malignancy 79 Wolf-Hervé Fridman T effector/memory cells, the ultimate control of metastasis in humans 85 Kari Alitalo Inhibition of lymphangiogenesis and metastasis 91 Shahin Rafii Contribution of CXCR4+VEGFR1+ pro-angiogenic hematopoietic cells to tumor oncogenesis 97 Part IV : Cancer stem cells 99 Paolo Comoglio Invasive growth : a MET-driven genetic program for cancer and stem cells 105 Hans Clevers Wnt and Notch cooperate to maintain proliferative compartments in crypts and intestinal neoplasia 111 Owen N.
    [Show full text]
  • Redundancy and Specificity F Mechta-Grigoriou Et Al 2379
    Oncogene (2001) 20, 2378 ± 2389 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc The mammalian Jun proteins: redundancy and speci®city Fatima Mechta-Grigoriou1, Damien Gerald1 and Moshe Yaniv*,1 1Unite des virus oncogenes, CNRS URA 1644, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France The AP-1 transcription factor is composed of a mixture transcription factors. These proteins are characterized of homo- and hetero-dimers formed between Jun and Fos by a highly charged, basic DNA binding domain, proteins. The dierent Jun and Fos family members vary immediately adjacent to an amphipathic dimerization signi®cantly in their relative abundance and their domain, referred as the `Leucine zipper' (Kouzarides interactions with additional proteins generating a and Zi, 1988; Landschulz et al., 1988). Dimerization complex network of transcriptional regulators. Thus, is required for speci®c and high anity binding to the the functional activity of AP-1 in any given cell depends palindromic DNA sequence, TGAC/GTCA (Rauscher on the relative amount of speci®c Jun/Fos proteins which et al., 1988; Gentz et al., 1989; Hirai and Yaniv, 1989; are expressed, as well as other potential interacting Ransone et al., 1989; Schuermann et al., 1989; Turner proteins. This diversity of AP-1 components has and Tjian, 1989). The dierent AP-1 dimers exhibit complicated our understanding of AP-1 function and similar DNA binding speci®cities but dier in their resulted in a paucity of information about the precise transactivation eciencies (Chiu et al., 1989; Hirai et role of individual AP-1 members in distinct cellular al., 1990; Kerppola and Curran, 1991b; Suzuki et al., processes.
    [Show full text]
  • NEWSLETTER – March 2016
    BRITISH SOCIETY FOR PROTEOME RESEARCH www.bspr.org UK Charity Number 1121692 Registered Company No.6319769 NEWSLETTER – March 2016 BSPR 2016 – PROTEOMIC APPROACHES TO HEALTH AND DISEASE University of Glasgow – 25-27 July 2016 th th The 2016 meeting of the Society will be held in the Western Infirmary Lecture Theatre building from Mon 25 – Wed 27 July 2016. For up to date information: (www.bspr.org/node/527) Abstract submission now open. Deadline: Mon 6th May. Registration opening shortly! Speakers include: Plenary - Matthias Mann – Max-Planck Institute for Biochemistry, Martinsried (GER) Rob Beynon (BSPR Lecturer 2016) – University of Liverpool (UK) Keynote: -Cancer: Judit Villen – University of Washington, Genome Sciences (US) Integration Omics: David Matthews – University of Bristol (UK) Metabolic disease: Harald Mischak – University of Glasgow (UK) Development and ageing: Xavier Druart - French Nat’l Inst for Agricultural Res, Nouzilly (FR) Nutrition/Lifestyle & Food Security: David Eckersall - University of Glasgow (UK) Infectious disease and Microbiome: Frank Schmidt – University of Greifswald (GER) New Technologies - Matthias Hentze – EMBL Heidelberg (GER) Data Analysis – Maria Martin – EMBL-EBI Cambridge (UK) Translation – Chris Sander, New York (US) More than 20 abstracts will be selected for oral presentation! Bursaries and Awards BSPR 2016 - The Society will be awarding the MJ Dunn Fellowship for attendance at BSPR 2016, and will also be awarding Bursaries to student members (£250) to enable them to attend a conference of their choice, including BSPR 2016. 10th European Summer School EMBO Workshop “Advanced Proteomics”, July 31st – August 6th, 2016. The Society will be awarding one or two bursaries (residential registration fee) to student members to enable them attend this workshop which will be held in Kloster Neustift, Brixen/Bressanone, South Tyrol, Italy.
    [Show full text]
  • The Helicase Ded1p Controls Use of Near-Cognate Translation Initiation Codons in 5Utrs
    The helicase Ded1p controls use of near- cognate translation initiation codons in 5# UTRs The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Guenther, Ulf-Peter et al. "The helicase Ded1p controls use of near- cognate translation initiation codons in 5# UTRs." Nature 559, 7712 (June 2018): 130–134. © 2018 Macmillan Publishers Ltd., part of Springer Nature As Published http://dx.doi.org/10.1038/s41586-018-0258-0 Publisher Springer Science and Business Media LLC Version Author's final manuscript Citable link https://hdl.handle.net/1721.1/125996 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike Detailed Terms http://creativecommons.org/licenses/by-nc-sa/4.0/ HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nature. Manuscript Author Author manuscript; Manuscript Author available in PMC 2018 December 27. Published in final edited form as: Nature. 2018 July ; 559(7712): 130–134. doi:10.1038/s41586-018-0258-0. The helicase Ded1p controls use of near-cognate translation initiation codons in 5′UTRs Ulf-Peter Guenther1,*, David E. Weinberg2,3,*, Meghan M. Zubradt2,4,*, Frank A. Tedeschi1, Brittany N. Stawicki1, Leah L. Zagore1, Gloria A. Brar5, Donny D. Licatalosi1, David P. Bartel3, Jonathan S. Weissman2,4, and Eckhard Jankowsky1,6,7 1Center for RNA Science and Therapeutics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA 2Department of Cellular and Molecular Pharmacology, University of California,
    [Show full text]
  • A N N U a L R E P O R T 2 0
    0 1 0 2 Acknowledgements T R HFSPO is grateful for the support of the following organizations: O P Australia E R National Health and Medical Research Council (NHMRC) L Canada A Canadian Institute of Health Research (CIHR) U Natural Sciences and Engineering Research Council (NSERC) N European Union N European Commission - A Directorate General Information Society (DG INFSO) European Commission - Directorate General Research (DG RESEARCH) France Communauté Urbaine de Strasbourg (CUS) Ministère des Affaires Etrangères et Européennes (MAEE) Ministère de l’Enseignement Supérieur et de la Recherche (MESR) Région Alsace Germany Federal Ministry of Education and Research (BMBF) India Department of Biotechnology (DBT), Ministry of Science and Technology Italy Ministry of Education, University and Research (CNR) Japan Ministry for Economy, Trade and Industry (METI) Ministry of Education, Culture, Sports, Science and Technology (MEXT) Republic of Korea Ministry of Education, Science and Technology (MEST) New Zealand Health Research Council (HRC) Norway Research Council of Norway (RCN) Switzerland State Secretariat for Education and Research (SER) United Kingdom The International Human Frontier Science Biotechnology and Biological Sciences Research Program Organization (HFSPO) Council (BBSRC) 12 quai Saint Jean - BP 10034 Medical Research Council (MRC) 67080 Strasbourg CEDEX - France Fax. +33 (0)3 88 32 88 97 United States of America e-mail: [email protected] National Institutes of Health (NIH) Web site: www.hfsp.org National Science Foundation (NSF) Japanese web site: http://jhfsp.jsf.or.jp HUMAN FRONTIER SCIENCE PROGRAM The Human Frontier Science Program is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontiers of the life sciences.
    [Show full text]